Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells.
Saved in:
| Title: | Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells. |
|---|---|
| Authors: | Mengeste AM; Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, P.O. Box 1068 Blindern, 0316, Oslo, Norway. a.m.mengeste@farmasi.uio.no., Katare P; Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, P.O. Box 1068 Blindern, 0316, Oslo, Norway., Dalmao Fernandez A; Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, P.O. Box 1068 Blindern, 0316, Oslo, Norway., Lund J; Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, P.O. Box 1068 Blindern, 0316, Oslo, Norway., Bakke HG; Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, P.O. Box 1068 Blindern, 0316, Oslo, Norway., Baker D; Bioscience Metabolism, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Bartesaghi S; Bioscience Metabolism, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Peng XR; Bioscience Metabolism, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Rustan AC; Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, P.O. Box 1068 Blindern, 0316, Oslo, Norway., Thoresen GH; Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, P.O. Box 1068 Blindern, 0316, Oslo, Norway.; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Kase ET; Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, P.O. Box 1068 Blindern, 0316, Oslo, Norway. |
| Source: | Molecular biology reports [Mol Biol Rep] 2022 Jul; Vol. 49 (7), pp. 6005-6017. Date of Electronic Publication: 2022 Apr 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-4978 (Electronic) Linking ISSN: 03014851 NLM ISO Abbreviation: Mol Biol Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35364719 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mengeste+AM%22">Mengeste AM</searchLink>; Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, P.O. Box 1068 Blindern, 0316, Oslo, Norway. a.m.mengeste@farmasi.uio.no.<br /><searchLink fieldCode="AU" term="%22Katare+P%22">Katare P</searchLink>; Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, P.O. Box 1068 Blindern, 0316, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Dalmao+Fernandez+A%22">Dalmao Fernandez A</searchLink>; Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, P.O. Box 1068 Blindern, 0316, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Lund+J%22">Lund J</searchLink>; Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, P.O. Box 1068 Blindern, 0316, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Bakke+HG%22">Bakke HG</searchLink>; Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, P.O. Box 1068 Blindern, 0316, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Baker+D%22">Baker D</searchLink>; Bioscience Metabolism, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Bartesaghi+S%22">Bartesaghi S</searchLink>; Bioscience Metabolism, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Peng+XR%22">Peng XR</searchLink>; Bioscience Metabolism, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Rustan+AC%22">Rustan AC</searchLink>; Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, P.O. Box 1068 Blindern, 0316, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Thoresen+GH%22">Thoresen GH</searchLink>; Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, P.O. Box 1068 Blindern, 0316, Oslo, Norway.; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Kase+ET%22">Kase ET</searchLink>; Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, P.O. Box 1068 Blindern, 0316, Oslo, Norway. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220403234%22">Molecular biology reports</searchLink> [Mol Biol Rep] 2022 Jul; Vol. 49 (7), pp. 6005-6017. <i>Date of Electronic Publication: </i>2022 Apr 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Reidel%22">Reidel </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>0403234 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-4978 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203014851%22">03014851 </searchLink><i>NLM ISO Abbreviation: </i>Mol Biol Rep <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35364719 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s11033-022-07387-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 6005 Titles: – TitleFull: Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mengeste AM – PersonEntity: Name: NameFull: Katare P – PersonEntity: Name: NameFull: Dalmao Fernandez A – PersonEntity: Name: NameFull: Lund J – PersonEntity: Name: NameFull: Bakke HG – PersonEntity: Name: NameFull: Baker D – PersonEntity: Name: NameFull: Bartesaghi S – PersonEntity: Name: NameFull: Peng XR – PersonEntity: Name: NameFull: Rustan AC – PersonEntity: Name: NameFull: Thoresen GH – PersonEntity: Name: NameFull: Kase ET IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2022 Jul Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1573-4978 Numbering: – Type: volume Value: 49 – Type: issue Value: 7 Titles: – TitleFull: Molecular biology reports Type: main |
| ResultId | 1 |